3 results
Approved WMOWill not start
To determine the performance of CardioFit* for the treatment of Class II-IV Heart Failure patients with preserved left ventricular function
Approved WMOCompleted
To investigate the pharmacokinetics of hospital pharmacy compounded CDCA capsules, compared to the commercial alternative.
Approved WMOCompleted
Primary ObjectiveTo assess the efficacy based on the proportion of subjects with SVR12, defined as HCV RNAgenotype 1 who are prior non-responders to pegIFNα-2a/RBV.Secondary Objectives• To assess efficacy, as determined by the proportion of subjects…